Saxagliptin


( Last Updated : May 28, 2012)
Generic Name:
Saxagliptin
Project Status:
Withdrawn
Therapeutic Area:
Diabetes mellitus, type 2
Manufacturer:
Bristol-Myers Squibb / AstraZeneca Canada Inc.
Call for patient/clinician input open:
Brand Name:
Onglyza
Project Line:
Reimbursement Review
Project Number:
SR0280-000
Call for patient/clinician input closed:

Details


Submission Type:
Resubmission
Indications:
Diabetes mellitus (Type 2)